CA
NZ
UK
AU
IND
US
…
Aedifica is a Belgian public regulated real estate company specializing in European healthcare real estate, particularly properties for elderly care. Aedifica has built a real estate portfolio worth approximately 12.4 billion euros in Belgium, Germany, the Netherlands, the United Kingdom, Finland, Ireland, Spain, France, and Italy. Aedifica is listed on Euronext Brussels (2006) and Euronext Amsterdam (2019) and is identified by the following codes: AED; AED:BB (Bloomberg); AOO.BR (Reuters). Since 2020, Aedifica has been a constituent of the BEL 20, the main stock market index of Euronext Brussels. Furthermore, since 2023, Aedifica has been included in the BEL ESG, the index that tracks the best-performing companies based on ESG criteria. Aedifica is also included in the EPRA, Stoxx Europe 600, and GPR indices. Its market capitalization was approximately 5.9 billion euros as of April 1, 2026. Aedifica NV/SA was established on November 07, 2005 and incorporated in 2005 in Belgium.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
Aedifica SA is a European real estate company that invests in healthcare real estate such as nursing homes and assisted-living facilities across several Western European countries. An ageing population and rising demand for long-term care could support rental income growth, while long-term leases and partnerships with care operators provide relatively predictable cash flows that may appeal to income-focused investors.
Key risks include exposure to rising interest rates and property valuation volatility, regulatory and reimbursement changes in healthcare, operator credit and occupancy risk, and execution risk from expansion across multiple jurisdictions.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2023-06-30 | 2022-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2023-06-30 | 2022-12-31 |
| Income before tax | 283.60M | 205.41M | -3.07M | 386.41M | 386.41M |
| Minority interest | -0.69M | -0.26M | 1.98M | 0.05M | 0.05M |
| Net income | 244.34M | 204.83M | 24.54M | 331.78M | 331.78M |
| Selling general administrative | 7.32M | 32.29M | 33.57M | 10.97M | 10.97M |
| Selling and marketing expenses | - | 0.65M | 0.72M | 1.03M | 1.03M |
| Gross profit | 348.43M | 326.16M | 301.46M | 267.32M | 267.32M |
| Reconciled depreciation | 2.96M | 2.90M | 3.65M | 3.49M | 3.49M |
| Ebit | 356.15M | 288.80M | 69.56M | 293.81M | 231.84M |
| Ebitda | 358.66M | 291.70M | 73.21M | 297.30M | 235.33M |
| Depreciation and amortization | 2.51M | 2.90M | 3.65M | 3.49M | 3.49M |
| Operating income | 319.15M | 275.59M | 95.25M | 297.24M | 297.24M |
| Other operating expenses | 58.12M | 72.14M | 225.87M | 47.39M | 47.39M |
| Interest expense | 55.89M | 83.39M | 72.63M | 25.10M | 25.10M |
| Tax provision | 38.58M | 0.31M | -25.62M | 54.67M | 54.67M |
| Interest income | 1.62M | 0.97M | 2.18M | 1.18M | 1.18M |
| Net interest income | -54.30M | -50.91M | -74.80M | -30.68M | -30.68M |
| Income tax expense | 38.57M | 0.31M | -25.62M | 54.67M | 54.67M |
| Total revenue | 370.05M | 347.73M | 321.11M | 277.07M | 277.07M |
| Total operating expenses | 24.71M | 50.57M | 206.47M | 37.64M | 37.64M |
| Cost of revenue | 25.57M | 21.57M | 19.65M | 9.75M | 9.75M |
| Total other income expense net | -35.55M | -70.19M | -98.31M | 89.17M | 89.17M |
| Net income from continuing ops | 245.12M | 205.09M | 22.55M | 331.73M | 331.73M |
| Net income applicable to common shares | - | - | - | 331.78M | 331.78M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2023-06-30 | 2022-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2023-06-30 | 2022-12-31 |
| Total assets | 6474.70M | 6463.82M | 6176.81M | 6085.54M | 6085.54M |
| Intangible assets | 0.59M | 1.05M | 1.66M | 1.86M | 1.86M |
| Other current assets | -15.77M | 111.54M | 85.85M | 0.99M | 102.46M |
| Total liab | 2806.77M | 2815.73M | 2595.91M | 2796.19M | 2796.19M |
| Total stockholder equity | 3662.33M | 3642.97M | 3575.86M | 3282.78M | 3282.78M |
| Other current liab | 47.35M | 38.53M | 43.74M | 54.09M | 31.91M |
| Common stock | 1203.19M | 1203.64M | 1203.64M | 1006.88M | 1006.88M |
| Capital stock | 1203.64M | 1203.64M | 1203.64M | 1006.88M | 1006.88M |
| Retained earnings | 380.11M | 340.93M | 161.44M | 448.80M | 448.80M |
| Other liab | - | - | - | 170.78M | 170.78M |
| Good will | 59.75M | 87.36M | 117.60M | 143.67M | 143.67M |
| Other assets | - | - | - | 13.77M | 13.77M |
| Cash | 21.94M | 18.45M | 18.25M | 13.89M | 13.89M |
| Total current liabilities | 551.08M | 522.27M | 407.31M | 532.21M | 532.21M |
| Current deferred revenue | - | - | -39.17M | - | - |
| Net debt | 2462.13M | 2576.11M | 2339.81M | 2514.10M | 2514.10M |
| Short term debt | 551.08M | 451.72M | 324.35M | 438.65M | 438.65M |
| Short long term debt | 551.29M | 448.44M | 321.55M | 435.16M | 435.16M |
| Short long term debt total | 2484.08M | 2594.56M | 2358.06M | 2527.99M | 2527.99M |
| Other stockholder equity | 1718.31M | 2098.41M | 2210.78M | 1827.10M | 1516.08M |
| Property plant equipment | - | - | - | 5622.27M | 5622.27M |
| Total current assets | 39.41M | 166.45M | 127.34M | 139.93M | 139.93M |
| Net tangible assets | - | - | - | 3137.26M | 3137.26M |
| Short term investments | - | - | 24.74M | - | -123.22M |
| Net receivables | 33.23M | 36.46M | 23.23M | 23.58M | 23.58M |
| Long term debt | 1933.72M | 2065.19M | 1958.75M | 2017.26M | 2017.26M |
| Inventory | - | - | - | - | 0.00M |
| Accounts payable | 31.92M | 30.62M | 39.17M | 39.48M | 39.48M |
| Accumulated other comprehensive income | 360.72M | - | 604.18M | - | 382.74M |
| Non currrent assets other | 135.30M | 6118.22M | 27.76M | 5792.85M | 5628.80M |
| Non current assets total | 6435.29M | 6297.37M | 6049.47M | 5945.61M | 5945.61M |
| Capital lease obligations | 85.32M | 80.93M | 77.76M | 75.57M | 75.57M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2023-06-30 | 2022-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2023-06-30 | 2022-12-31 |
| Investments | - | -259.55M | -258.80M | -683.41M | -683.41M |
| Change to liabilities | - | - | - | 0.00M | 0.00M |
| Total cashflows from investing activities | -43.75M | -259.55M | - | -683.41M | -683.41M |
| Net borrowings | -28.86M | 232.49M | - | 370.61M | 370.61M |
| Total cash from financing activities | -215.18M | 11.25M | 33.63M | 463.37M | 463.37M |
| Change to operating activities | - | - | - | 5.60M | 5.60M |
| Net income | 244.34M | 204.83M | 24.54M | 331.78M | 331.78M |
| Change in cash | 5.69M | 0.20M | 4.36M | -1.44M | -1.44M |
| Begin period cash flow | 16.26M | 18.25M | 13.89M | 15.34M | 15.34M |
| End period cash flow | 21.94M | 18.45M | 18.25M | 13.89M | 13.89M |
| Total cash from operating activities | 262.43M | 248.50M | 229.53M | 218.60M | 218.60M |
| Issuance of capital stock | 0.00M | 0.00M | 374.21M | 251.42M | 251.42M |
| Depreciation | 2.51M | 2.90M | 3.65M | 3.49M | 3.49M |
| Other cashflows from investing activities | 0.00M | -151.74M | - | -8.30M | -8.30M |
| Dividends paid | 185.58M | 166.85M | 115.99M | 119.08M | 119.08M |
| Sale purchase of stock | - | - | - | - | 0.18M |
| Other cashflows from financing activities | -0.75M | -54.38M | -52.31M | 331.02M | 331.02M |
| Change to netincome | - | - | - | -122.27M | -122.27M |
| Capital expenditures | 0.34M | 0.61M | 0.99M | 0.86M | 0.86M |
| Change in working capital | 25.23M | -24.91M | -29.22M | 5.60M | 5.60M |
| Stock based compensation | - | - | - | - | 0.07M |
| Other non cash items | -9.66M | 65.67M | 230.56M | -122.27M | -122.27M |
| Free cash flow | 262.09M | 247.89M | 228.54M | 217.73M | 217.73M |
Sector: Real Estate Industry: REIT - Healthcare Facilities
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| AEDFF Aedifica SA |
- -% |
82.43 | 13.30 | 12.80 | 18.34 | 1.55 | 23.61 | 24.72 |
| WELL Welltower Inc |
1.43 0.61% |
234.60 | 170.68 | 72.46 | 7.75 | 2.13 | 9.77 | 27.67 |
| VTR Ventas Inc |
1.09 1.30% |
84.80 | 161.02 | 131.58 | 7.08 | 3.12 | 9.07 | 24.46 |
| OHI Omega Healthcare Investors Inc |
0.14 0.30% |
46.98 | 16.83 | 10.13 | 11.78 | 2.66 | 14.30 | 12.72 |
| DOC Healthpeak Properties Inc |
0.09 0.48% |
19.03 | 164.70 | 113.64 | 4.06 | 1.58 | 7.64 | 13.08 |
Aedifica is a Belgian public regulated real estate company specializing in European healthcare real estate, particularly properties for elderly care. Aedifica has built a real estate portfolio worth approximately 12.4 billion euros in Belgium, Germany, the Netherlands, the United Kingdom, Finland, Ireland, Spain, France, and Italy. Aedifica is listed on Euronext Brussels (2006) and Euronext Amsterdam (2019) and is identified by the following codes: AED; AED:BB (Bloomberg); AOO.BR (Reuters). Since 2020, Aedifica has been a constituent of the BEL 20, the main stock market index of Euronext Brussels. Furthermore, since 2023, Aedifica has been included in the BEL ESG, the index that tracks the best-performing companies based on ESG criteria. Aedifica is also included in the EPRA, Stoxx Europe 600, and GPR indices. Its market capitalization was approximately 5.9 billion euros as of April 1, 2026. Aedifica NV/SA was established on November 07, 2005 and incorporated in 2005 in Belgium.
| Name | Title | Year Born |
|---|---|---|
| Mr. Stefaan Gielens | MD, CEO, Exec. Director & Exec. Mang. | 1965 |
| Ms. Ingrid Daerden | Exec. Director, CFO & Exec. Mang. | 1974 |
| Mr. Raoul Thomassen | COO & Exec. Director | 1974 |
| Mr. Charles-Antoine Van Aelst | Exec. Director, Chief Investment Officer & Exec. Mang. | 1986 |
| Mr. Sven Andre Bogaerts | Exec. Director, Chief Mergers & Acquisitions Officer, Chief Legal Officer and Exec. Mang. | 1977 |
| Delphine Noirhomme | Investor Relations Mang. | NA |
| Mr. Thomas Moerman | Gen. Counsel & Compliance Officer | NA |
| Ms. Martina Carlsson | Control & Communication Mang. | NA |
| Mr. Stefaan Gielens | MD, CEO, Executive Director & Executive Manager | 1965 |
| Ms. Ingrid Daerden | Executive Director, CFO & Executive Manager | 1974 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.
Download a free report with stock ideas and industry insights for general information.
Download Free Report Now →
Basic Materials
-1.82%
Communication Services
-0.22%
Consumer Cyclical
-0.13%
Consumer Defensive
+0.32%
Energy
+0.15%
Financial Services
-0.85%
Financials
+2.34%
Healthcare
-1.28%
Industrials
-0.96%
Real Estate
-0.38%
Technology
-2.73%
Utilities
-0.31%
Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.
Portfolio
Watchlist
Please wait processing your request...